All filters
Slidesets
Tyrosine Kinase Inhibitor (TKI) - B. Lum
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
A pre-clinical PKPD framework for biomarker led - R. Jones
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
A survey of new oncology drug approvals in the [...] - B. Lum
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Dose escalation of tamoxifen in patients with low ... -C. Lee
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Toxicity-adjusted dose (TAD) of sunitinib - H. Gurney
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Dried blood spot sampling for therapeutic drug - D. De Wit
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Drug-drug interactions in patients ... - R. van Leeuwen
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Dose Individualization in H[...] - Courtney Fletches, PharmD
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Everolimus exposure strongly related to dose [...]-D. De Wit
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Marker of bevacizumab efficacy - C. Serdjebi
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Microdosing as a pharmacokinetic assessment tool - W. Vaes
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Modeling as a tool to individualize - Joga Gobburu, PhD, MBA
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Obstacles to use dose optimization in an [...] - Rene Bruno, PhD
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Optimal TDM and pharmacodynamics of mitotane - S. Ackland
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Is cancer different - George Demetri, MD
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Pharmacology as a tool to dose individualize [...] - Mark Ratain, MD
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Population PKPD modeling of abexinostat-induced - S. Fouliard
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Polymorphisms of nr1i2 and nr1i3 - L. Mbatchi
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
The use of PKPD modeling early in drug - Lena Friberg, PhD
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015